An affordable microneedle skin patch that delivers a controlled dosage of medicine directly into the body, eliminating the need for injections or oral medication, has been developed by a team led by scientists at the University of Bath.
It is hoped that the patches, which are described in the journal Biomaterials Advances, will be ready for use within the next five to 10 years.
What makes the microneedle patches unique is that they are made from a hydrogel (a gel-like substance in which water forms the liquid component), with the active ingredient encapsulated inside the hydrogel microneedle structure rather than in a separate reservoir.
They are also more affordable than other commercially available microneedle patches, as they are produced from 3D printed molds. Molds produced this way are easy to customize, which keeps the costs down.